text: Yo, SARS-CoV-2 be causin' a global health crisis,
  We need some solutions, prognosis needs to be precise.
  Check it, we got plasma proteome fingerprintin',
  Predictin' high-risk and low-risk COVID-19 conditions.
  
  Using machine learnin' and laser desorption ionization,
  We analyzed the proteome, no need for hesitation.
  Sample prep, MS, and data analysis on point,
  Accuracy at 92%, we ain't disappoint.
  
  Sensitivity at 93%, specificity 92%,
  Without feature selection, we keep it true.
  MALDI-TOF profile showed two regions distinct,
  Proteoforms in the mix, man, it's quite distinct.
  
  With SDS-PAGE and bottom-up proteomics,
  We found serum amyloid A proteins, it's no gimmicks.
  They're biomarkers for viral infections, acute phase,
  Identifyin' high-risk COVID-19, we blaze.
  
  Using a clinical technology, noninvasive prognosis,
  Distinguishin' patients, we the dopest.
  Validation's needed to solidify its utility,
  But we on the right track, no futility.